Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate for sedation in nerve block procedures and painless diagnostic or therapeutic procedures
ChiCTR2200066534Phase 4Recruiting
- Sponsor
- The First People's Hospital of Yunnan Province
- Start
- Aug 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and sufentanil (8 arms), sponsored by The First People's Hospital of Yunnan Province. Primary endpoint: Hypoxemia. Started Aug 2021; status: recruiting.
02
Drugs
remimazolampropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2200066534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066534.